Trial Summary
What is the purpose of this trial?
This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: * Patient reported outcomes (PRO), using the EQ-5D questionnaire * Clinical outcomes
Eligibility Criteria
Inclusion Criteria
Eligibility for the Extension Study is contingent upon having completed the REN-007 study.
Treatment Details
Participant Groups
2Treatment groups
Experimental Treatment
Group I: RBT-1Experimental Treatment1 Intervention
Patients undergoing CABG, valve, or combined CABG/valve surgery
Group II: PlaceboExperimental Treatment1 Intervention
Patients undergoing CABG, valve, or combined CABG/valve surgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
Renibus Therapeutics, Inc.
Lead Sponsor
Trials
8
Recruited
1,200+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.